RISK OF HOSPITALIZATION OR DEATH DUE TO HEART FAILURE WITH INTENSIVE GLUCOSE-LOWERING THERAPY IN DIABETIC WOMEN: SUBGROUP ANALYSES BY HISTORY OF CARDIOVASCULAR DISEASE IN THE ACCORD TRIAL

Background: Patients with type 2 diabetes (T2D) and cardiovascular disease (CVD) often exhibit myocardial insulin resistance, potentially contributing to morbidity and mortality. In a prior secondary analysis of publicly available ACCORD data, we noted increased hospitalization or death due to heart